KLK3 and Familial prostate cancer: In other words, 26% of subjects with a PSA density ≥0.08 ng/mL/cc truly had clinically significant prostate cancer, and 96% of subjects with a PSA density <0.08 ng/mL/cc truly did not have clinically significant prostate cancer.